SCHEMBL4451323

SCHEMBL4451323

COC(=O)c1ccc(CCN)cc1F

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 3/20 0.47
GAA P10253 3/20 0.47
KDM4E B2RXH2 3/20 0.47
ALDH1A1 P00352 3/20 0.47
MAPT P10636 2/20 0.47
HPGD P15428 2/20 0.47
HSD17B10 Q99714 2/20 0.47
ALOX15 P16050 1/20 0.47
TAAR1 Q96RJ0 2/20 0.46
MAPK1 P28482 1/20 0.46
LMNA P02545 2/20 0.45
GLA P06280 2/20 0.45
CYP1A2 P05177 1/20 0.45
CYP3A4 P08684 1/20 0.45
NFKB1 P19838 1/20 0.45
ATM Q13315 2/20 0.45
LOXL2 Q9Y4K0 1/20 0.45
FFAR4 Q5NUL3 1/20 0.44
MEN1 O00255 1/20 0.44
APEX1 P27695 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL12499751 0.98 LMNA (0.47) TSHRGAAKDM4EALDH1A1MAPT
SCHEMBL507332 0.89 LOXL2 (0.54) TSHRGAAKDM4EALDH1A1MAPT
SCHEMBL4453621 0.87 TSHR (0.51) TSHRGAAKDM4EALDH1A1MAPT
Hydrochloric Acid SCHEMBL1169323 0.87 LOXL2 (0.53) TSHRGAAKDM4EALDH1A1MAPT
SCHEMBL3921415 0.87 CYP4A11 (0.54) TSHRGAAKDM4EALDH1A1MAPT
SCHEMBL7219535 0.87 NPC1 (0.44) TSHRGAAKDM4EALDH1A1MAPT
SCHEMBL23582917 0.86 FFAR4 (0.47) TSHRGAAKDM4EALDH1A1MAPT
SCHEMBL27600987 0.86 FFAR4 (0.43) TSHRGAAKDM4EALDH1A1MAPT
SCHEMBL8252765 0.85 GAA (0.47) TSHRGAAKDM4EALDH1A1MAPT
SCHEMBL20772253 0.84 CYP4A11 (0.58) TSHRGAAKDM4EALDH1A1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090275583-A1 ANTIVIRAL COMPOUNDS AND USE THEREOF MYRIAD GENETICS, INCORPORATED (US) 2009-11-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090275583-A1 ANTIVIRAL COMPOUNDS AND USE THEREOF MAVS, ZC3HAV1, EIF2AK2 TSHR 4811/4885GAA 79/4885KDM4E 2622/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.